Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
George R. Thompson, Oliver A. Cornely, Peter G. Pappas, Thomas F. Patterson, Martin Hoenigl, Jeffrey D. Jenks, Cornelius J. Clancy, M. Hong Nguyen
Abstract
Pulmonary aspergillosis has been increasingly reported following severe respiratory viral infections. Millions have been infected by SARS-CoV-2, placing large numbers of patients at-risk for COVID-19 associated pulmonary aspergillosis (CAPA). Prompt recognition of this syndrome and is paramount to improve outcomes.
Topics & Concepts
SuperinfectionMedicineAspergillosisPulmonary aspergillosisCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineVirologyImmunologyVirusPathologyInfectious disease (medical specialty)DiseaseAntifungal resistance and susceptibilityInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisAntimicrobial Resistance in Staphylococcus